Original Drugs Pave the Way for Follow-on-Biologics

Time:June 05-05, 2014

Organizer:BrightTALK

  • Share on Facebook
  • Tweet
  • Post to Tumblr
  • Pin it
  • Add to Pocket
  • Submit to Reddit
  • Share on LinkedIn
  • Publish on WordPress
  • Save to Pinboard
  • Send email

With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.

 

Why you should attend:

·Learn about the growth of follow-on-biologics

·Identify the drivers and restraints

·Discuss trends in technology development

Jun 18 2013

29 mins

Tel:400-610-1188

E-mail:cphiservice@ubmsinoexpo.com

PharmaSources Customer Service